Publicaciones (155) Publicaciones de Alvaro Lassaletta Atienza

2024

  1. Chemotherapy in pediatric low-grade gliomas (PLGG)

    Child's Nervous System

  2. Clinical and biological landscape of constitutional mismatch-repair deficiency syndrome: an International Replication Repair Deficiency Consortium cohort study

    The Lancet Oncology, Vol. 25, Núm. 5, pp. 668-682

  3. Continuous response despite reduced dose of trametinib as single agent in an adolescent with a relapsed disseminated pediatric low-grade glioma KIAA1549-BRAF fusion positive: a case report and review of the literature

    Frontiers in Oncology, Vol. 14

  4. ECLIM-SEHOP: how to develop a platform to conduct academic trials for childhood cancer

    Clinical and Translational Oncology

  5. Palliative care for children with central nervous system tumors: results of a Spanish multicenter study

    Clinical and Translational Oncology, Vol. 26, Núm. 3, pp. 786-795

2023

  1. Asparaginase activity monitoring in pediatric acute lymphoblastic leukemia: A cross-sectional nationwide study in Spain

    Cancer Reports, Vol. 6, Núm. 2

  2. Development of a centralised triage centre for children with cancer and blood disorders in response to the humanitarian crisis in Ukraine

    The Lancet Oncology

  3. Double-Blind, Placebo-Controlled Study of Bezlotoxumab in Children Receiving Antibacterial Treatment for Clostridioides difficile Infection (MODIFY III)

    Journal of the Pediatric Infectious Diseases Society, Vol. 12, Núm. 6, pp. 334-341

  4. Haploidentical vs. HLA-matched donor hematopoietic stem-cell transplantation for pediatric patients with acute lymphoblastic leukemia in second remission: A collaborative retrospective study of the Spanish Group for Bone Marrow Transplantation in Children (GETMON/GETH) and the Spanish Childhood Relapsed ALL Board (ReALLNet)

    Frontiers in Pediatrics, Vol. 11

  5. Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institution

    Clinical and Translational Oncology, Vol. 25, Núm. 5, pp. 1268-1276

  6. Neurocognitive outcomes in pediatric brain tumors after treatment with proton versus photon radiation: a systematic review and meta-analysis

    World Journal of Pediatrics, Vol. 19, Núm. 8, pp. 727-740

  7. Nivolumab with or without ipilimumab in pediatric patients with high-grade CNS malignancies: Safety, efficacy, biomarker, and pharmacokinetics-CheckMate 908

    Neuro-Oncology, Vol. 25, Núm. 8, pp. 1530-1545

  8. Outcomes of Infants and Young Children With Relapsed Medulloblastoma After Initial Craniospinal Irradiation Sparing Approaches: An International Cohort Study

    Journal of Clinical Oncology, Vol. 41, Núm. 10, pp. 1921-1932

  9. Phase II Trial of Dabrafenib Plus Trametinib in Relapsed/Refractory BRAF V600 Mutant Pediatric High-Grade Glioma

    Journal of Clinical Oncology, Vol. 41, Núm. 33, pp. 5174-5183

  10. Response and resistance to BRAFV600E inhibition in gliomas: Roadblocks ahead?

    Frontiers in Oncology

  11. Role of urine culture in paediatric patients with cancer with fever and neutropenia: A prospective observational study

    Archives of Disease in Childhood, Vol. 108, Núm. 12, pp. 982-986

  12. Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial

    JAMA Oncology, Vol. 9, Núm. 12, pp. 1688-1695

2022

  1. Clinical and molecular characteristics of pediatric low-grade glioma complicated with ventriculo-peritoneal shunt related ascites

    Journal of Neuro-Oncology, Vol. 157, Núm. 1, pp. 147-156

  2. Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war

    The Lancet Haematology

  3. How a pediatric neuro-oncology unit was managed in Madrid during the first wave of the COVID-19 pandemic

    Tumori, Vol. 108, Núm. 6, pp. 552-555